Exploring the Relationship between Statin Therapy and Diabetes Mellitus: Unraveling the Complex Interplay of Lipid Lowering and Glucose Dysregulation – A Review

Abstract

Statin therapy, renowned for its efficacy in managing dyslipidemia and reducing cardiovascular risk, has been associated with an unintended side effect— the development of diabetes mellitus. This review explores the intricate relationship between statin use and the risk of new-onset diabetes, shedding light on the underlying mechanisms and clinical implications. Epidemiological evidence has established a link between statin therapy and an increased incidence of diabetes, particularly in certain patient populations. The exact mechanisms triggering this diabetogenic effect remain elusive, encompassing a spectrum of potential pathways such as insulin resistance, beta-cell dysfunction, and impaired glucose homeostasis. This comprehensive review synthesizes current knowledge on the impact of different statin types, dosages, and treatment durations on diabetes risk. Furthermore, it delves into genetic predispositions and individual patient factors that may contribute to the variability in statin-induced diabetes susceptibility. The review also explores potential strategies for identifying high-risk patients and mitigating the adverse metabolic effects of statins. In addition, the paper discusses the paradoxical relationship between the cardiovascular benefits of statins and the associated diabetogenic risk. It addresses the challenges clinicians face in balancing the advantages of lipid-lowering therapy with the potential for worsening glucose metabolism. Finally, the review highlights emerging research avenues, including the exploration of novel biomarkers and genetic markers that could predict an individual's susceptibility to statin-induced diabetes. It calls for further prospective studies and clinical trials to refine our understanding of this complex interplay and develop personalized approaches to optimize the cardiovascular benefits of statins while minimizing the risk of diabetes. In conclusion, this review provides a comprehensive overview of the current state of knowledge regarding statin-induced diabetes, offering valuable insights for healthcare professionals, researchers, and policymakers involved in cardiovascular disease management and prevention.